In vitro effects of some drugs on human erythrocyte glutathione reductase

J Enzyme Inhib Med Chem. 2012 Feb;27(1):18-23. doi: 10.3109/14756366.2011.572879. Epub 2011 Jul 8.

Abstract

The effects of ketotifen, meloxicam, phenyramidol-HCl and gadopentetic acid on the enzyme activity of GR were studied using human erythrocyte glutathione reductase (GR) enzymes in vitro. The enzyme was purified 209-fold from human erythrocytes in a yield of 19% with 0.31 U/mg. The purification procedure involved the preparation of haemolysate, ammonium sulphate precipitation, 2'',5'-ADP Sepharose 4B affinity chromatography and Sephadex G-200 gel filtration chromatography. Purified enzyme was used in the in vitro studies. In the in vitro studies, IC(50) values and K(i) constants were 0.012 mM and 0.0008 ± 0.00021 mM for ketotifen; 0.029 mM and 0.0061 ± 0.00127 mM for meloxicam; 0.99 mM and 0.4340 ± 0.0890 mM for phenyramidol-HCl; 138 mM and 28.84 ± 4.69 mM for gadopentetic acid, respectively, showing the inhibition effects on the purified enzyme. Phenyramidol-HCl showed competitive inhibition, whereas the others showed non-competitive inhibition.

MeSH terms

  • Dose-Response Relationship, Drug
  • Erythrocytes / enzymology*
  • Gadolinium DTPA / pharmacology*
  • Glutathione Reductase / antagonists & inhibitors*
  • Glutathione Reductase / isolation & purification
  • Glutathione Reductase / metabolism*
  • Humans
  • Ketotifen / pharmacology*
  • Meloxicam
  • Pyridines / pharmacology*
  • Structure-Activity Relationship
  • Thiazines / pharmacology*
  • Thiazoles / pharmacology*

Substances

  • Pyridines
  • Thiazines
  • Thiazoles
  • Glutathione Reductase
  • Gadolinium DTPA
  • phenyramidol
  • Meloxicam
  • Ketotifen